REPL

NASD Replimune Group, Inc.
Oct 2, 2026 · 2:38 AM ET EOD Market Closed

$13.45 ↑ +0.00 (+0.00%) Trading Up from the previous close of $13.45, $0.14 below the day’s high of $13.59

YTD change
+38.37%
vs 20-day SMA
-0.29%
vs 200-day SMA
+51.12%

Price ranges

Previous day
$12.65 $13.66
open $12.99 close $13.24
+$0.25 (+1.92%)
Today
$13.06 $13.59
open $13.26 now $13.45
+$0.19 (+1.43%)
Past week
$12.07 $13.66
from $12.96 now $13.45
+$0.49 (+3.78%)
Past month
$12.07 $16.33
from $15.67 now $13.45
-$2.22 (-14.17%)
This year
$1.50 $16.33
from $9.72 now $13.45
+$3.73 (+38.37%)

Price & Performance

+5.84 (+76.74%) / 6M

$0.5576$6.08$11.60$17.12Apr 1Jul 1Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 75.5% away from all-time highs of $54.85
  • REPL is up 38% since the beginning of the year
  • REPL is up 219% over the past 12 months
  • REPL is down 14% over the past 1 month
  • 26% of all REPL investors are betting against REPL

REPL reads very good: price sits above one of the two key moving averages, the 12-month move is +219.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.72
Earnings momentum +8.2% Quarterly EPS growth
Quarterly change +8.2%

Valuation

P/E ratio N/A
Enterprise value $1.2B
Beta 1.46

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$195.3M
Debt$112.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.3B

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
BNTX BioNTech SE Sponsored ADR $96.85 -1.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.